Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146-157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The article discusses the challenges in developing effective vaccines for respiratory viruses such as SARS-CoV-2 and influenza. These viruses often replicate rapidly in the […]
Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146–157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The authors discuss the challenges in developing effective vaccines for respiratory viruses like influenza and SARS-CoV-2. They highlight that these viruses replicate rapidly in
Reference: Yonker, L. M., Swank, Z., Bartsch, Y. C., et al. (2023). Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis. Circulation, 147, xxx–xxx. https://doi.org/10.1161/CIRCULATIONAHA.122.061025 Summary: This study investigates the immunological profiles of adolescents and young adults who developed myocarditis following mRNA COVID-19 vaccination. The research involved blood sampling from 16 patients hospitalised with myocarditis
Reference: Kirsch, S. (2023). What you need to know about COVID vaccine safety. COVID-19 Early Treatment Fund. Retrieved from [insert URL] Summary: In his article, Steve Kirsch argues that COVID vaccines may be more harmful than beneficial, suggesting that for every life saved by vaccination, two people may die due to vaccine-related complications, creating a
Reference: Krauson, A. J., Casimero, F. V. C., Siddiquee, Z., & Stone, J. R. (2023). Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients. npj Vaccines, 8, 141. https://doi.org/10.1038/s41541-023-00742-7 Summary: This study investigates the persistence of SARS-CoV-2 mRNA vaccines in human tissues, focusing on recently vaccinated patients. Autopsies
Reference: Pfizer. (2023). NCT04368728 FDA Clinical Trial: C4591001. Retrieved from [link to the document] Summary: The clinical trial NCT04368728, with protocol number C4591001, aims to evaluate the safety, tolerability, immunogenicity, and efficacy of RNA vaccine candidates against COVID-19 in healthy individuals. The trial is structured in three phases, assessing different doses and age groups, with
Reference: The Exposé. (2022, December 26). PfizerGate: Tragic truth behind COVID vaccines: 50k Brits have died suddenly in 8 months due to vaccination causing a 5-month countdown to death. https://expose-news.com/2022/12/26/pfizergate-50k-brits-died-suddenly-covid-vaccination Summary: The article by The Exposé raises alarming concerns regarding an unprecedented rise in deaths in Britain since the introduction of COVID-19 vaccines. Official statistics
Reference: Chiu, S.-N., Chen, Y.-S., Hsu, C.-C., Hua, Y.-C., Tseng, W.-C., Lu, C.-W., Lin, M.-T., Chen, C.-A., Wu, M.-H., Chen, Y.-T., Hung Chien, T.-C., Tseng, C.-L., & Wang, J.-K. (2023). Changes of ECG parameters after BNT162b2 vaccine in senior high school students. European Journal of Pediatrics, 1-11. https://doi.org/10.1007/s00431-022-04786-0 Summary: This study assessed changes in ECG
Reference: Gøtzsche, P. C., & Demasi, M. (2022). Serious harms of the COVID-19 vaccines: A systematic review. medRxiv. https://doi.org/10.1101/2022.12.06.22283145 Summary: This systematic review by Gøtzsche and Demasi critically examines the serious adverse events (SAEs) associated with COVID-19 vaccinations, highlighting significant underreporting in clinical trial data. The review synthesises findings from 18 systematic reviews, 14 randomised